CRO Marc Boroditsky sold 7,000 shares
Company: Nebius
The claim, verbatim
CRO Marc Boroditsky sold 7,000 shares at an average $209.08 ($1,463,560) under a Rule 10b5-1 plan, leaving 5,000 shares.
Source (primary)
Nebius Group (NASDAQ:NBIS) Stock Jumps 4.5% - Should You Buy? - MarketBeat (-, news_article)
View cached copy (2026-10-03)Live source ↗
Quote: “CRO Marc Boroditsky sold 7,000 shares of the stock in a transaction dated Monday, September 14th.”
How we checked this
Checked on October 12, 2026. The cited source supports every part of this claim.
The article's insider-trading section reports Boroditsky's sale of 7,000 shares at an average of $209.08 for $1,463,560 under a Rule 10b5-1 plan, leaving him with 5,000 shares. Elsewhere the article's news summary says the chief revenue officer sold his entire directly held position, which conflicts with the 5,000 shares remaining, but the detailed figures support every part of the claim.
Confirmed in the source:
- CRO Marc Boroditsky sold 7,000 shares of Nebius Group stock
- The shares were sold at an average price of $209.08
- The sale had a total value of $1,463,560
- The transaction was executed under a pre-arranged Rule 10b5-1 trading plan
- Following the sale, Boroditsky owned 5,000 shares
What we did: Read our cached copy of the publisher (https://www.marketbeat.com/instant-alerts/price-nebius-group-nasdaq-nbis-stock-jumps-45-should-you-buy-2026-10-02/) in full (20,238 characters, retrieved October 3, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Nebius Group (NASDAQ:NBIS) Stock Jumps 4.5% - Should You Buy? - MarketBeat
Quote: “CRO Marc Boroditsky sold 7,000 shares of the stock in a transaction dated Monday, September 14th.”
confirms Nebius Group (NASDAQ:NBIS) Shares Climb 7.4% - Here's Why - MarketBeat
Quote: “CRO Marc Boroditsky sold 7,000 shares of the firm's stock in a transaction on Monday, September 14th”